Search
for

    Sort by

    Research 961–990 of 1000+

    1. Genetic variants in AR and SHBG and resistance to hormonal castration in prostate cancer Medical Oncology · 2013 · 6 citations
    2. Diabetes Mellitus and Prostate Cancer Risk—A Systematic Review and Meta-Analysis Cancers · 2024 · 3 citations
    3. Low-Dose Dimethyl Sulfoxide (DMSO) Suppresses Androgen Receptor (AR) and Its Splice Variant AR-V7 in Castration-Resistant Prostate Cancer (CRPC) Cells Therapeutics · 2025
    4. Risk factors for prostate cancer: An umbrella review of prospective observational studies and mendelian randomization analyses PLoS medicine · 2024
    5. Medical management of benign prostatic hyperplasia Cleveland Clinic journal of medicine · 2024
    6. Analysis of benign prostatic obstruction surgery: A long-term evaluation in a real-life context Archivio italiano di urologia, andrologia · 2022
    7. 1747 PREDICTION OF BLADDER PROSTATIC OBSTRUCTION: DEVELOPMENT OF A SIMPLIFIED CLINICAL NOMOGRAM The Journal of Urology · 2013
    8. Finasteride and prostate cancer 2011
    9. 412 DETECTION OF CIRCULATING PROSTATE CANCER CELLS BY MEANS OF AN ANTIBODY-CONJUGATED NANOPARTICULAR BIOSENSOR European Urology Supplements · 2011
    10. Risk factors for prostate cancer: a case-control study investigating selected key exposures and their interactions with predisposition genes Jurnal Natural (Faculty of Mathematics and Natural Science, Syiah Kuala University) · 2010
    11. Slow progress in prostate cancer BJUI · 2007
    12. RE: EFFECT OF THE DUAL 5α-REDUCTASE INHIBITOR DUTASTERIDE ON MARKERS OF TUMOR REGRESSION IN PROSTATE CANCER 2005
    13. Estudo do estroma reativo prostático após a orquiectomia bilateral e posterior inibição da atividade da aromatase pela crisina e inibição da atividade da 5-alfa-redutase pela finasterida 2020
    14. Risk factors for prostate cancer: a case-control study in Greece International Journal of Cancer · 1999 · 127 citations
    15. Doxil (Caelyx): an exploratory study with pharmacokinetics in patients with hormone-refractory prostate cancer Anti-cancer drugs · 2000 · 81 citations
    16. Novel Anti-Prostate Cancer Curcumin Analogues That Enhance Androgen Receptor Degradation Activity Anti-Cancer Agents in Medicinal Chemistry · 2009 · 73 citations
    17. Androgenetic alopecia and prostate cancer: findings from an Australian case-control study. PubMed · 2002 · 21 citations
    18. Recent discoveries and developments of androgen receptor based therapy for prostate cancer MedChemComm · 2015 · 17 citations
    19. The influence of <i>Castanea sativa</i> Mill. flower extract on hormonally and chemically induced prostate cancer in a rat model Food & Function · 2021 · 7 citations
    20. Change in Prostate Specific Antigen Concentration in Men with Prostate Specific Antigen Less than 2.5 ng/ml Taking Low Dose Finasteride or Dutasteride for Male Androgenetic Alopecia The Journal of Urology · 2017 · 1 citations
    21. Review of hair prosthetic options for patients with alopecia Journal of cosmetic dermatology · 2023
    22. Evaluation of the CNC® prosthetic system in recurrent breast cancer patients with chemotherapy-induced alopecia: a pilot study BMC women's health · 2022
    23. Fluxactive Complete (#1 PREMIUM PROSTATE SUPPORT FORMULA) Managing Prostate Wellness And Bladder Functions! Zenodo (CERN European Organization for Nuclear Research) · 2022
    24. Identification of seven new prostate cancer susceptibility loci through a genome-wide association study UNC Libraries · 2020
    25. Photoacoustic imaging for prostate brachytherapy cIRcle (University of British Columbia) · 2014
    26. Management of Advanced Prostate Cancer Undergoing Major Shift Oncology times · 2011
    27. Urological Oncology: Prostate Cancer 2010
    28. How not to detect prostate cancer Lancet Oncology · 2007
    29. Effects of the androgen receptor overexpression in prostate cancer 2007
    30. TRAIL sensitization of PC3 prostate cancer cells by doxorubicin can be blocked by the anti-oxidant N-acetyl-cysteine or by the iron chelator deferoxamine Clinical Cancer Research · 2006